U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Friday it would require Impax Laboratories Inc and privately held Amneal Pharmaceuticals LLC to divest rights to 10 generic medications as a condition of their merger.
from Reuters: Health News https://reut.rs/2KndamW
http://bit.ly/2zwRqiM
April 27, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 27, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.